• Markets
    • icon
  • Companies
IPD · ASX

Impedimed Limited (ASX:IPD)

AU$0.14

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
HALO Price Momentum HALO Ords GROWTH AUS EMA 125 Breakdown All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IPD Overview

IPD Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IPD

Website

Impedimed Limited

Telephone

61.7.3860.3700

Address

Unit 1 50 Parker Court Pinkenba, Queensland (QLD) 4008

Description

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

IPD Price Chart

Key Stats

Market Cap

AU$283.25M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.06 - 0.24

Trade Value (12mth)

AU$112,660.00

1 week

3.7%

1 month

21.74%

YTD

86.67%

1 year

52.17%

All time high

1.73662

Key Fundamentals

EPS 3 yr Growth

-68.200%

EBITDA Margin

-179.60%

Operating Cashflow

-$18m

Free Cash Flow Return

-31.90%

ROIC

-36.30%

Interest Coverage

-599.40

Quick Ratio

8.70

Other Data

Shares on Issue (Fully Dilluted)

1822m

HALO Sector

Healthcare

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.27

IPD Announcements

Latest Announcements

Date Announcements

31 October 23

Appendix 4C & Quarterly Activities Report - Sep-23 Qtr

×

Appendix 4C & Quarterly Activities Report - Sep-23 Qtr

31 October 23

Notice of Annual General Meeting and Voting Form

×

Notice of Annual General Meeting and Voting Form

31 October 23

Virtual Meeting Online Guide

×

Virtual Meeting Online Guide

31 October 22

Change of Director's Interest Notice - Mrs Janet West AM

×

Change of Director's Interest Notice - Mrs Janet West AM

31 October 22

Change of Director's Interest Notice - Mr Donald Williams

×

Change of Director's Interest Notice - Mr Donald Williams

31 October 22

Change of Director's Interest Notice - Mr David Anderson

×

Change of Director's Interest Notice - Mr David Anderson

31 October 22

Change of Director's Interest Notice - Correction

×

Change of Director's Interest Notice - Correction

31 October 08

AGM Presentation - Confirms Growth Prospects

×

AGM Presentation - Confirms Growth Prospects

31 July 23

Notice received under section 203D of the Corporations Act

×

Notice received under section 203D of the Corporations Act

31 July 23

Five Additional Medical Policies Achieved

×

Five Additional Medical Policies Achieved

31 January 22

Appendix 4C & Quarterly Activities Report

×

Appendix 4C & Quarterly Activities Report

31 August 23

Appendix 4E

×

Appendix 4E

31 August 23

2023 Annual Report

×

2023 Annual Report

31 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 October 14

AGM Presentation

×

AGM Presentation

30 November 23

2023 AGM - Chair's Address and Presentation

×

2023 AGM - Chair's Address and Presentation

30 November 23

IPD AGM - Results of Meeting

×

IPD AGM - Results of Meeting

30 May 23

Share Purchase Plan Opens

×

Share Purchase Plan Opens

30 March 23

Change of Director's Interest Notice - Mr Richard Valencia

×

Change of Director's Interest Notice - Mr Richard Valencia

30 March 09

Presentation for Australian and US Investment Roadshow

×

Presentation for Australian and US Investment Roadshow

30 June 23

Revised Security Trading Policy

×

Revised Security Trading Policy

30 January 23

New Version of NCCN Guidelines for Breast Cancer

×

New Version of NCCN Guidelines for Breast Cancer

30 January 23

Appendix 4C & Quarterly Activities Report - Dec-22 Qtr

×

Appendix 4C & Quarterly Activities Report - Dec-22 Qtr

30 August 23

Response to Notice 249D from IPDs Executive Leadership Team

×

Response to Notice 249D from IPDs Executive Leadership Team

30 August 22

Director Appointment & Retirement

×

Director Appointment & Retirement

30 August 22

Initial Director's Interest Notice - Mrs Janet West

×

Initial Director's Interest Notice - Mrs Janet West

30 August 18

Annual Report 30 June 2018

×

Annual Report 30 June 2018

IPD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 52.1 31.4 3.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.9 24.2 -10.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -10.6 -15.4 -5.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.03 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.02 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -41.8 84.3 2.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,202 1,679 1,800 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,202 1,679 1,800 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 8 11 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.5 25.7 7.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 11 8 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -12 -13 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.3 -9.4 -2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -145.1 -126.3 -120.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 245 226 220 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -21 -18 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 13.4 -10.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -253.5 -174.7 -179.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 3 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -23 -21 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock 9.8 7.8 -7.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -273.7 -200.9 -201.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -22 -21 -22 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -21 -20 -21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 3.1 4.0 -3.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -246.2 -188.1 -180.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 -16 -18 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 5 6 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -5 -6 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 16 40 28 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -13 -16 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.0 -18.0 -17.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.6 -1.5 -1.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 20 41 46 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 59 69 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -19 -41 -44 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 9 8 8 Lock Lock Lock
Equity $m Lock Lock Lock Lock 26 51 61 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 26 51 62 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.9 98.8 21.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -60.5 -33.9 -29.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -84.9 -55.0 -40.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -77.3 -51.8 -36.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -49.5 -40.8 -31.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -409.9 -659.2 -599.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.9 2.2 2.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -75.3 -79.5 -72.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.2 6.4 8.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.1 6.3 8.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 76.7 87.3 88.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -163.0 -216.3 -308.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.8 2.4 2.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 33.4 36.9 28.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.5 0.3 0.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 15.4 25.0 11.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -267.0 -203.0 -194.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -65.6 -36.5 -32.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -60.5 -33.9 -29.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 10.9 9.9 12.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 197.8 155.1 141.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 208.8 165.0 153.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 29.1 29.3 29.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 179.7 135.7 124.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.27%

Value ($M)

1

Prior Change

-0.10%

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IPD Shortsell

Frequently Asked Questions

The current share price of Impedimed Limited (IPD:ASX) is AU$0.14.
The 52-week high share price for Impedimed Limited (IPD:ASX) is AU$0.24.
The 52-week low share price for Impedimed Limited (IPD:ASX)? is AU$0.06.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) has a franking level of 0%.
Impedimed Limited (IPD:ASX) is classified in the Healthcare.
The current P/E ratio for Impedimed Limited (IPD:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.